Danaher Corp (DHR) Valuation

Based on the GoodMoat Investment Framework's valuation assessment, Danaher Corp is trading at a price that does not offer a margin of safety. The current price of $187.15 is more than double the GoodMoat Target of $93.20, implying a margin of safety of approximately -100%. According to the framework's bands, any margin of safety below 10% is considered 'Unfavourable,' and a negative figure indicates the stock is priced well above the estimated intrinsic value. The forward P/E of 36.6x is significantly higher than the sector average for healthcare, which typically ranges in the low-to-mid 20s. This multiple is also high relative to the company's current revenue growth of 4.6% YoY; the framework notes that a P/E of 25-26x can be reasonable for a 50% grower but is high for a slower grower. While Danaher is a high-quality business, its valuation multiples are not justified by its current growth profile, placing it in the 'Extreme Valuation' red flag category. For a value investor seeking a margin of safety, the stock is expensive relative to its quality and growth, making the current entry point unfavourable without a substantial price correction.